ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,208.27
-0.66%
Dow Jones
38,571.03
-0.30%
Gold vs US Dollar
2,331.33
-0.84%
Brent Oil
76.785
-1.73%
Bitcoin
68,702.82
-0.15%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. VBI Vaccines Inc (VBIV)

  7. VBI Vaccines Inc (VBIV) News

VBI Vaccines (VBIV)

VBI Vaccines Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VBIV
DateTimeSourceHeadlineSymbolCompany
29/05/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
29/05/202413:00Business WireVBI Vaccines Announces New Tumor Response Data from Ongoing Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma PatientsNASDAQ:VBIVVBI Vaccines Inc
24/05/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
22/05/202413:00Business WireVBI Vaccines Announces Poster Presentation at 2024 ASCO Annual Meeting Highlighting New Interim Phase 2b Data from VBI-1901 in Recurrent Glioblastoma PatientsNASDAQ:VBIVVBI Vaccines Inc
15/05/202421:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
15/05/202421:00Business WireVBI Vaccines Reports First Quarter 2024 Financial ResultsNASDAQ:VBIVVBI Vaccines Inc
16/04/202413:00Business WireVBI Vaccines Reports Full Year 2023 Financial ResultsNASDAQ:VBIVVBI Vaccines Inc
11/04/202421:05Business WireVBI Vaccines Announces Closing of $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:VBIVVBI Vaccines Inc
09/04/202419:45Business WireVBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:VBIVVBI Vaccines Inc
03/04/202413:00Business WireVBI Vaccines Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent GlioblastomaNASDAQ:VBIVVBI Vaccines Inc
02/04/202413:00Business WireVBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine PlatformNASDAQ:VBIVVBI Vaccines Inc
14/02/202413:34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
14/02/202412:00Business WireVBI Announces Agreement to Sell Manufacturing Capabilities, Certain Related Assets, and Enter Into New License Agreement with Brii BiosciencesNASDAQ:VBIVVBI Vaccines Inc
06/02/202421:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
23/01/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
11/01/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
26/12/202321:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
12/12/202321:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
29/11/202321:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
20/11/202313:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
20/11/202313:00Business WireVBI Vaccines Presents Additional Biomarker Data from Phase 1/2a Study of VBI-1901 in Recurrent GBM at the 2023 Society for Neuro-Oncology (SNO) Annual MeetingNASDAQ:VBIVVBI Vaccines Inc
14/11/202321:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
14/11/202321:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VBIVVBI Vaccines Inc
14/11/202321:05Business WireVBI Vaccines Reports Third Quarter 2023 Financial ResultsNASDAQ:VBIVVBI Vaccines Inc
03/11/202321:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
26/10/202313:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
26/10/202313:00Business WireVBI Vaccines Expands Proprietary Technology Platforms With Development of a Novel mRNA-Launched eVLP Vaccine ProgramNASDAQ:VBIVVBI Vaccines Inc
27/09/202312:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
27/09/202312:30Business WireVBI Vaccines’ Pan-Coronavirus Vaccine Candidate, VBI-2901, Induced Broad and Durable Protective Titers Against Variants of ConcernNASDAQ:VBIVVBI Vaccines Inc
07/09/202313:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
 Showing the most relevant articles for your search:NASDAQ:VBIV

Your Recent History

HUOB
IOTXETH
IoTeX Network
LSE
ZX30
Citi Fun 24
BIT
P1VCL0
NLBNPIT1VCL0 20991231 19...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved